n-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance

American Journal of Clinical Nutrition

Volumn 65, Issue 6, 1997, Pages 1874-1881

  Sirtori, Cesare R ^a   Paoletti, Rodolfo ^b   Mancini, Mario ^b   Crepaldi, Gaetano ^b   Manzato, Enzo ^b   Rivellese, Angela ^b   Pamparana, Franco ^b   Stragliotto, Eduardo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Fish oil; Hypertriglyceridemia; Impaired glucose tolerance; Insulin resistance; n 3 Fatty acids; Non insulin dependent diabetes mellitus; Syndrome X

Indexed keywords

HEMOGLOBIN A1C; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FAT INTAKE; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030938197     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/65.6.1874     Document Type: Article

References (57)

1. Leaf A, Weber PC. Cardiovascular effects of n - 3 fatty acids. N Engl J Med 1988;318:549-57.
2. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
3. Schmidt EB, Dyerberg J. Omega-3 fatty acids: current status in cardiovascular medicine. Drugs 1994;47:405-24.
4. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989;30:785-807.
5. Von Shacky C, Fisher S, Weber PC. Long term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function and eicosanoid formation in humans. J Clin Invest 1985;76:1626-31.
6. Tremoli E, Eligini S, Colli S, et al. n - 3 Fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor by adherent monocytes. Arterioscler Thromb 1994;14:1600-8.
7. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1994;14:1425-9.
8. Glauber H, Wallace P, Griver K, Brechtel G. Adverse effects of ω-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 1988;108:663-8.
9. Kassim S, Stern B, Khilnani S, McLin P, Baciorowski S, Jen KL. Effect of omega-3 fish oils on lipid metabolism, glycemic control and blood pressure in type II diabetic patients. J Clin Endocrinol Metab 1988;67:1-5.
10. Stacpoole PW, Alig J, Ammon L, Crockett SE. Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia. Metabolism 1989;38:946-56.
11. Zambon S, Friday KE, Childs MT, Fujimoto WY, Bierman EL, Ensinck JW. Effect of glyburide and ω-3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1992;56:447-54.
12. Friday KE, Childs MT, Tsunehara CH, Fujimoto WY, Bierman EL, Ensinck JW. Omega-3 fatty acid supplementation raises plasma glucose while lowering triglyceride levels in type II diabetes. Diabetes Care 1989;12:276-81.
13. Ezaki O, Tsuji E, Momomura K, Kasuga M, Itakura H. Effects of fish and safflower oil feeding on subcellular glucose transporter distributions in rat adipocytes. Am J Physiol 1992;263:E94-101.
14. Rillaerts EG, Engelmann GJ, Van Camp KM, De Leeuw I. Effect of omega-3 fatty acids in diet of type I diabetic subjects on lipid values and hemorheological parameters. Diabetes 1989;38:1412-6.
15. Bagdade JD, Buchanan WE, Levy RA, Subbaiah PV, Ritter MC. Effects of ω-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with NIDDM. Diabetes 1990;30:426-31.
16. Annuzzi G, Rivellese A, Capaldo B, et al. A controlled study on the effects of n - 3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 1991;87:65-73.
17. Westerveld HT, de Graaf JC, van Breugel HHFI, et al. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 1993;16:683-8.
18. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T. Effects of n - 3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 1995;123:911-8.
19. Eritsland J, Deljeflot I, Abdelnoor M, Arnesen H, Torjesen PA. Longterm effects of n - 3 fatty acids on serum lipids and glycaemic control. Scand J Clin Lab Invest 1994;54:273-80.
20. Grundt H, Nilsen DWT, Hetland Ø, et al. Improvement of serum lipids and blood pressure during intervention with n - 3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia. J Intern Med 1995;237:249-59.
21. Connor WE. Diabetes, fish oil, and vascular disease. Ann Intern Med 1995;123:950-2.
22. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
23. Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Circulation 1972;55:501-8.
24. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
25. 2+ precipitation procedure for quantitation of high-density lipoprotein. Clin Chem 1982;28:1379-88.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
27. Davis H, McDonald JM, Jarrett J. A high performance liquid chromatography method for haemoglobin A1c. Diabetes 1978;27:102-7.
28. Debaquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 1971;33:732-8.
29. Marangoni F, Angeli MT, Colli S, et al. Changes of n - 3 and n - 6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta 1993;1210:55-62.
30. Lorenz R, Spengler U, Fischer S, Duhm J, Weber PC. Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 1983;67:504-11.
31. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n - 3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995;332:977-82.
32. Harris WS, Muzio F. Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr 1993;58:68-74.
33. Tremoli E, Maderna P, Marangoni F, et al. Prolonged inhibition of platelet aggregation following n - 3 fatty acid ethyl ester administration to healthy volunteers. Am J Clin Nutr 1995;61:607-13.
34. Vessby B, Boberg M. Dietary supplementation with n - 3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1990;228:165-71.
35. Kohout M, Kohoutova B, Heimberg M. The regulation of hepatic triglyceride metabolism by free fatty acids. J Biol Chem 1971;246:5067-74.
36. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987;237:885-8.
37. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid. Diabetes 1991;40:280-9.
38. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993;328:238-44.
39. Belzung F, Raclot T, Groscolas R. Fish oil n - 3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 1993;264:R1111-8.
40. Connor WE, Prince MJ, Ullmann D, et al. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann N Y Acad Sci 1993;683:337-40.
41. Moller DE, Flier JS. Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med 1991;325:938-48.
42. Galli C, Tremoli E, Stragliotto E, Sirtori CR. Treatment with omega-3 fatty acid ethyl esters in hyperlipoproteinemias: comparative studies on lipid metabolism and thrombotic indexes. Pharmacol Res 1995;31:1-8.
43. Friday KE, Failor RA, Childs MT, Bierman EL. Effects of n - 3 and n - 6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia. Arterioscler Thromb 1991;11:47-54.
44. Sirtori CR, Gatti E, Tremoli E, et al. Olive oil, corn oil, and n - 3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia. Am J Clin Nutr 1992;56:113-22.
45. Sirtori CR, Franceschini G. Effects of fibrates on serum lipids and atherosclerosis. Pharmacol Ther 1988;37:167-91.
46. Sirtori CE, Galli C, Franceschini G. Fraudulent (and non fraudulent) fatty acids for human health. Eur J Clin Invest 1993;23:686-9.
47. Franceschini G, Calabresi L, Maderna P, Galli C, Gianfranceschi G, Sirtori CR. ω-3 Fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers. Metabolism 1991;40:1283-6.
48. Huff MW, Telford DE, Edmonds BW, McDonald CG, Evans AJ. Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil. Biochim Biophys Acta 1993;1210:113-22.
49. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb 1992;12:647-56.
50. Brinton EA, Oram JF, Bierman EL. The effect of variations in lipid composition of high-density lipoprotein on its interaction with receptors on human fibroblasts. Biochim Biophys Acta 1987;920:68-75.
51. Manzato E, Zambon A, Lapolla A, et al. Lipoprotein abnormalities in well-treated type II diabetic patients. Diabetes Care 1993;16:469-75.
52. Hallaq H, Smith TW, Leaf A. Modulation of dihydropyridine sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U S A 1992;89:1760-4.
53. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-33.
54. Bønaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. N Engl J Med 1990;322:795-801.
55. Howard WJ. Is it time for a clinical trial of dietary fish oil supplementation in individuals with NIDDM? Ann N Y Acad Sci 1993;683:394-405.
56. Desprès JP. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease? Can Med Assoc J 1993;148:1339-40.
57. Miller Bass K, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993;153:2209-16.